2022
DOI: 10.7717/peerj.12991
|View full text |Cite
|
Sign up to set email alerts
|

Butyrate promotes oral squamous cell carcinoma cells migration, invasion and epithelial-mesenchymal transition

Abstract: Background Oral squamous cell carcinoma (OSCC), the most common type of primary malignant tumor in the oral cavity, is a lethal disease with high recurrence and mortality rates. Butyrate, a metabolite produced by periodontal pathogens, has been linked to oral diseases. The purpose of this study was to evaluate the effect of sodium butyrate (NaB) on the proliferation, migration, and invasion of OSCC cells in vitro and to explore the potential mechanism. Methods Two OSCC cell lines (HSC-4 and SCC-9) were treat… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
6
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(6 citation statements)
references
References 52 publications
0
6
0
Order By: Relevance
“…Oral epithelial cells are sensitive to SCFAs [ 39 ]. For instance, butyrate decreased intercellular adhesion molecule 1 (ICAM1) expression in the oral squamous carcinoma cell line HSC2 [ 40 ] and promoted the migration and invasion of carcinoma cells [ 41 ]. Butyrate inhibits the proliferation of HSC3 and HSC4 [ 42 ] and the human oral squamous carcinoma cell lines SCC-1 and SCC-9 [ 43 ].…”
Section: Introductionmentioning
confidence: 99%
“…Oral epithelial cells are sensitive to SCFAs [ 39 ]. For instance, butyrate decreased intercellular adhesion molecule 1 (ICAM1) expression in the oral squamous carcinoma cell line HSC2 [ 40 ] and promoted the migration and invasion of carcinoma cells [ 41 ]. Butyrate inhibits the proliferation of HSC3 and HSC4 [ 42 ] and the human oral squamous carcinoma cell lines SCC-1 and SCC-9 [ 43 ].…”
Section: Introductionmentioning
confidence: 99%
“…The growth blockade of anaplastic thyroid cancer cells with initially high cytoplasmic E-cadherin accumulation was accompanied by a translocation of E-cadherin to the cell membrane [ 24 ]. Inversely, the application of the HDAC-inhibitor butyrate to oral squamous cell carcinoma cells with initially high membrane-bound E-cadherin promoted E-cadherin translocation to the cytoplasm [ 25 ]. Artesunate, an antimalarial, has been shown to block tumor growth in the colorectal cancer cell lines Lovo (poorly differentiated) and HT-29 (well differentiated).…”
Section: Discussionmentioning
confidence: 99%
“…In recent years, there has been an increase in the incidence of OSCC, according to growing evidence ( Zang et al, 2022 ). It adversely affects the appearance and quality of life in OSCC patients.…”
Section: Discussionmentioning
confidence: 99%